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This article introduced the work of ethylcellulose based polymeric microsphere loaded with nifedipine
for reduction in frequency of administration with low solubility in aqueous medium and high rate of
absorption in the stomach. The non-aqueous polymeric suspension was put dropwise into an aqueous
medium containing polyvinyl alcohol as a surfactant for the synthesis of microsphere by solvent eva-
poration. The microspheres were characterized by different techniques, namely, XRD, SEM, and NMR. The
formation of microspheres was conﬁrmed by SEM. XRD analysis revealed the semi-crystallinity nature of
microspheres. The NMR study indicated the presence of hetero-aromatic nucleus in the microsphere.
& 2015 Xi'an Jiaotong University. Production and hosting by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Controlled release dosage form covers a wide range of pro-
longed actions that provide continuous release of their ingredients
at a predetermined time. One such approach is using polymeric
microsphere as carriers of drugs [1]. As a result, the drug is loca-
lized on the targeted site. Hence, surrounding tissues are not af-
fected by the drug [2]. Drug release modiﬁcation has been in-
vestigated to control the time of drug release and maintain con-
stant drug bioavailability [3]. An optimal amount of drug delivery
to the target tissue with a right period of time is very necessary so
that the agent can induce little toxicity and minimal side effects
[4]. The drug release from different formulations depend on the
extent of cross-linking, morphology and size of microspheres [5]. It
has been shown that reduction of either the applied dose or the
frequency of administration gives better pharmacological results
compared with administration of conventional doses of drugs [4].
Usually an increase in hardness of a dosage form is accompanied
by a decrease in release rate, due to a decrease in porosity [6].
Microspheres have been widely accepted as a means to achieve an
oral and parenteral controlled release drug delivery system [7].
Microspheres are better tolerated in the form of sustained releaseon and hosting by Elsevier B.V. Th
University.of nifedipine for their conventional counterparts and dosage [8].
Nifedipine is a prototype dihydropyridine calcium channel blocker
with a rapid onset and a short duration of action [9]. Calcium
channel antagonists 1,4-dihydropyridine acting with a high degree
of lipophilicity display a slow onset action after administration as
vasodilator and hypertensive medication commercialized [10].
However, there have been few studies on ethylcellulose as a
polymeric biomaterial through the evaporation method. Forma-
tion of porous or hollow microspheres and spherical shapes were
controlled during processing which were easy to fabricate due to
the solvent/non-solvent phase separation taking place in small
polymer-solvent droplets in a continuous non-solvent phase. The
solvent evaporation method was a cost-effective process that did
not require expensive chemical agents and instruments. Hence,
the purpose of this study was to investigate the physico-chemical
parameters, such as surface morphology, crystallinity, and ele-
mental composition of microspheres through scanning electron
microscopy (SEM), 1H nuclear magnetic resonance (NMR) and
X-ray diffractometry (XRD) described in this article.2. Materials and methods
2.1. Synthesis
Ethylcellulose microspheres were prepared by the solvent eva-
poration method. Nifedipine (gift from J.B Pharma, India) andis is an open access article under the CC BY-NC-ND license
Table 1
Elemental quantiﬁcation of carbon and oxygen.
Materials Carbon (%) Oxygen (%) Impurity (%)
Nifedipine pure 73.29 26.45 0.26
Ethylcellulose 53.60 40.81 5.59
Dummy microsphere 57.37 35.83 6.8
Nifedipine microsphere 69.58 27.72 2.7
Nifedipine microsphere focused 68.64 29.29 2.07
P. Parida et al. / Journal of Pharmaceutical Analysis 6 (2016) 341–344342ethylcellulose (purchased from Merck, India) with a total weight of
1 g were dissolved in 10 mL. Dichloromethane (purchased from
Merck, India) was used as the internal phase. Microspheres were
prepared with three different drugs to polymer concentration in ratio
of 10%, 20% and 30%. The internal phase was then added dropwise to
a 0.5% (w/v) solution of polyvinyl alcohol (purchased from S.D. Fine-
Chem Limited, India) in water. The mixture was constantly stirred at
500 rpm using an overhead stirrer (Remi Equipments Pvt. Ltd.,
Mumbai, India) up to 5 h for complete evaporation of methylene
chloride. Microspheres were then ﬁltered and rinsed three times
with distilled water and dried at room temperature.
2.2. Scanning electron microscopy
Nifedipine microspheres were dried overnight and analyzed
through SEM. Microsphere composites were given a conductive
platinum coating of 600 Å in a thick, sputter ion coater. These sam-
ples were examined through SEM (JEOL JSM-6480LV, Japan) which
was well equipped with a backscattered electron detector for ima-
ging and performing the energy dispersive X-ray analysis (EDXA) for
elemental composition analysis where particular elements were
identiﬁed. In this method a focused electron beam was used to scan
the sample in parallel lines. For SEM characterization, microspheres
were then mounted on a sample holder followed by coating with a
conductive metal such as platinum or zirconium using a sputter
coater. The sample was then scanned with a focused ﬁne beam of
electrons. The surface characteristics of the sample were obtained
from the secondary electrons emitted from the sample surface. The
microsphere must be able to withstand vacuum and the electronFig. 1. SEM of solid microspheres (A), microsphere of varying in size (B), surface morphbeam can damage the polymer. The mean size obtained by SEM was
comparable with results obtained by dynamic light scattering.
2.3. NMR analysis
At room temperature of 21.7 °C, 1H NMR (400 MHz) spectra
were recorded using a JOEL FT NMR (AL400) Spectroscope, Japan.
The internal standard CDC13 (δH¼δC¼0) and speciﬁc deuterated
solvent were used in the experiments. Chemical shift displace-
ment (δ) was expressed in parts per million where 2 mg of sample
diluted with 0.5 mL of CDCl3 solution was kept in the sample
holder and brought to analysis.
2.4. Powder X-ray diffractometry
X-ray diffracted peaks were obtained using the Philips X'Pert
on powder diffraction coordination (Philips Analytical, the Neth-
erlands) set with a directly set up goniometer in the Bragg-ology (C), perforated microsphere (D, E), and smooth surface of microspheres (F).
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30 kV and 20 mA, using the CuKα line at 1.54056 Å as the radiation
source. The samples were ground using a mortar and pestle. The
crushed specimen was ﬁlled and arranged in a specimen holder
made of aluminum. Samples were scanned from 10° to 90° (2θ)
and in stage sizes of 0.020, with count time of 2.00 s, using anFig. 2. EDX spectra of nifedipine pure (A), nifedipine microspheres (B), and focused
nifedipine microsphere (C).automatic divergence slit assembly with a proportional detector.
The samples were scanned at 25 °C. Relative intensities were read
from the strip charts and corrected to ﬁx slit values.3. Results and discussion
3.1. Morphology by SEM
Formulation of microspheres depends on some factors like
type, amount of solvent, polymer used and processing time. It wasFig. 3. 1H NMR spectra data for nifedipine pure drug (A) and nifedipine micro-
sphere (B).
Fig. 4. Combined XRD data for nifedipine (s-1), ethylcellulose (s-2), polyvinyl al-
cohol (s-3), nifedipineþethylcellulose (s-4), dummy microsphere (s-5), perforated
nifedipine microsphere (s-6), nifedipine microsphere (s-7). Where θ is for nifedi-
pine, α is for ethylcellulose, δ is for polyvinyl alcohol.
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(Fig. 1A and B). Perforated spheres formed due to decrease in
solvent from the preparation of polymeric suspension where rapid
evaporation took place during processing. The formation of voids
might be related to the mechanisms of air bubbles or, entrapped
ﬂuid formed during the cross-linking and solidiﬁcation process.
These spheres were naked to achieve more exposure in dissolution
media that decreases the sustained release property (Fig. 1D and
E). At uniform rotation of stirrer, solidiﬁcation found to be very
sensitive to the time factor for evaporation of solvent from the
polymeric suspension led to the formation of solid microspheres. It
was observed that when the rotation of stirrer increased above
600 rpm then there were formation of foam-like materials. Uni-
form stirring rate of magnetic stirrer made the spheres solid and
more spherical. The microsphere surface became smooth and non-
porous, which was effective in delayed dissolution (Fig. 1A–C).
Furthermore, both types of microspheres had a regular spherical
morphology (Fig. 1A–E). The surfaces of the two types changed, as
could be seen at a high magniﬁcation (Fig. 1C and D). The surface
of the standard microspheres was smooth (Fig. 1F). Surface irre-
gularity of microspheres was caused by irregular solvent eva-
poration with respect to time.
3.2. Elemental composition through SEM
Energy dispersive spectroscopy displayed the variations in %
composition of pure drug, polymer, dummy microspheres and
nifedipine microspheres. The elemental analysis data gave the
composition and concentration of carbon and oxygen. The oxygen
concentration of nifedipine microspheres slightly decreased due to
inter-hydrogen bonding with respect to the nifedipine pure drug
as described in Table 1. There were differences in carbon and
oxygen concentration at 0.94% and 1.57% in nifedipine micro-
spheres as a whole (Fig. 2B) and back scattered with a single mi-
crosphere surface (Fig. 2A) respectively, where 0.63% was the
difference in impurities found between them. EDX spectra of drug
and nifedipine microspheres with a control region had no other
impurities, besides the grid coating material platinum and zirco-
nium shown. The quantitative data indicated about the speciﬁc
concentration of carbon and oxygen in microspheres (Fig. 2C).
3.3. NMR results
Prominent peaks were observed for 1H NMR (CDCl3) of nife-
dipine: δ¼1.61 (d, 6H, CH3), 2.31 (s, 3H, CH3), 3.56 (d, 6H, OCH3),
7.24 (s, 2H, aromatic), 7.49 (s, 1H, aromatic) (Fig. 3A) and for ni-
fedipine microsphere: 1H NMR (CDCl3): δ¼1.13 (d, 6H, CH3), 2.32
(s, 3H, CH3), 3.56 (d, 6H, OCH3), 7.24 (s, 2H, aromatic), 7.47 (s, 1H,
aromatic) (Fig. 3B). Assay results obtained by NMR conﬁrmed the
presence of prominent methyl, carboxyl ester group as well as
hetero-aromatic groups. The presence of molecular fragments in-
dicated that, the formulation retained its active nucleus and
functional groups of drug in the composite after the preparation.
Identical spectral data were found from nifedipine microsphere
with respect to nifedipine raw material.
3.4. Phase analysis by XRD
The XRD patterns of raw materials and prepared samples were
taken. It was observed that the broad peaks in a diffractogramwere at around 19.6° and 21.8° for nifedipine, 18.92° for ethylcel-
lulose, and 19.5° for polyvinyl alcohol (Fig. 4). The following data
illustrate the comparative X-ray powder diffraction pattern of ni-
fedipine, physical mixture of nifedipine with ethylcellulose, mi-
crospheres without nifedipine, solid and perforated nifedipine
microspheres (evaluated from JCPDF, Origin lab, X-pert high score).
The XRD proﬁle of nifedipine microsphere indicates that the ma-
terial is low crystalline. Pure nifedipine and individual polymers
were in the crystalline state as is known from its sharp peak. Ni-
fedipine microspheres without drug gave a glassy structure. In the
case of perforated microsphere the crystallinity decreased (Fig. 4).
However, decreases in the peak intensity and the baseline shift of
the diffractogram were observed due to presence of polymers in
microspheres when compared to the physical mixture of nifedi-
pine along with ethylcellulose. This might be due to decrease in
crystalline of drug that followed dispersal in the polymer matrix of
nifedipine microsphere.4. Conclusions
There is variation in size of microspheres from 50 to 1000 μm.
In comparison of elemental composition analysis, it was found
that variations at carbon and oxygen contents illustrated the de-
gree of interaction. The microspheres containing nifedipine were
partly crystalline state during processing. It is also concluded that
NMR spectra identify the presence of active groups of compound
in the formulation.References
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